Skip to main content
Toggle navigation
Login
Search
Home
Conference Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
Browse by Poster Presenter
Browse by Poster Presenter
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
O
O'Brien, Grace
Metrum Research Group
(
W-088
)
pmparams: an R Package for Defining and Formatting Parameter Tables in Pharmacometric Modeling
Grace O'Brien
Favorite
Oh, Elise
Gilead Sciences, Inc.
(
W-089
)
Modeling Lenacapavir (LEN) Exposure After Daily Oral Administration Alone and in Combination with Bictegravir (BIC) in People with HIV: A Population Pharmacokinetic Approach
Elise Oh
Favorite
Okada, Hiroki
Kyowa Kirin, Inc.
(
M-084
)
Population Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Analysis of Burosumab in Patients with X-Linked Hypophosphatemia Aged <12 Months
Hiroki Okada
Favorite
(
M-085
)
PBPK-mQSP Model Analysis of KHK4951, an Eye Drop Formulation of Tivozanib, a Potent and Selective VEGF Receptor Inhibitor
Hiroki Okada
Favorite
Oka, Takaaki
Daiichi Sankyo Co., Ltd.
(
T-094
)
Cellular and Humoral Semi-mechanistic Immune Response Models of a Vaccine Candidate for Respiratory Syncytial Virus Infection
Takaaki Oka
Favorite
Oladoyinbo, Olayide
Pfizer Canada
(
M-086
)
Population Pharmacokinetic (Pop PK) Modeling of Nirmatrelvir/Ritonavir in Severe Renal Impaired Participants with COVID-19 either on or not on Hemodialysis
Olayide Oladoyinbo
Favorite
Osawa, Mayu
Bristol Myers Squibb
(
M-087
)
Model Platform to Predict Long-Term Clinical Outcome for Patients with Relapsed and Refractory Multiple Myeloma (RRMM)
Mayu Osawa
Favorite
